NCT03326310 2025-12-29Selumetinib and Azacitidine in High Risk Chronic Blood CancersUniversity of ChicagoPhase 1 Recruiting18 enrolled
NCT01290302 2025-06-12Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs VidazaAmerican Regent, Inc.Phase 1 Completed38 enrolled 14 charts
NCT02129101 2019-10-30Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid MalignanciesMayo ClinicPhase 1 Completed63 enrolled
NCT00351975 2014-12-23Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesNational Cancer Institute (NCI)Phase 1 Completed56 enrolled